Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 2/20 | 0.57 |
| ▸ | CALCR | P30988 | 5/20 | 0.54 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.53 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.53 |
| ▸ | NMUR2 | Q9GZQ4 | 3/20 | 0.52 |
| ▸ | NMUR1 | Q9HB89 | 3/20 | 0.52 |
| ▸ | APLNR | P35414 | 1/20 | 0.51 |
| ▸ | MC4R | P32245 | 1/20 | 0.51 |
| ▸ | MC5R | P33032 | 1/20 | 0.51 |
| ▸ | MC3R | P41968 | 1/20 | 0.51 |
| ▸ | MC1R | Q01726 | 1/20 | 0.51 |
| ▸ | NPY1R | P25929 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.51 |
| ▸ | NPY4R | P50391 | 1/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.51 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32679453 | 0.90 | C5AR1 (0.56) | EPHA2CALCRRAMP3OPRM1OPRD1 | |
| SCHEMBL30454832 | 0.89 | EPHA2 (0.57) | EPHA2 | |
| SCHEMBL30584470 | 0.88 | EPHA2 (0.56) | EPHA2CALCRRAMP3OPRM1OPRD1 | |
| SCHEMBL30883247 | 0.85 | RAMP3 (0.57) | EPHA2CALCRRAMP3C5AR1NMUR2 | |
| SCHEMBL29561936 | 0.85 | NMUR2 (0.64) | EPHA2CALCRRAMP3NMUR2NMUR1 | |
| SCHEMBL30906437 | 0.85 | EPHA2 (0.61) | EPHA2CALCRRAMP3NMUR2NMUR1 | |
| SCHEMBL31307232 | 0.84 | EPHA2 (0.56) | EPHA2CALCRRAMP3OPRM1OPRD1 | |
| SCHEMBL30906381 | 0.84 | NPY2R (0.63) | EPHA2CALCRRAMP3NPY1RNPY2R | |
| SCHEMBL32670411 | 0.84 | EPHA2 (0.68) | EPHA2CALCRRAMP3OPRM1OPRD1 | |
| SCHEMBL30335928 | 0.84 | EPHA2 (0.68) | EPHA2CALCRRAMP3OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023122721-A2 | PEPTIDES FOR CELL-TYPE SPECIFIC TARGETING OF THE RETINA | OREGON STATE UNIVERSITY (US) | 2023-06-29 | — | — | WO | claimed |
| US-20240343760-A1 | PEPTIDES FOR CELL-TYPE SPECIFIC TARGETING OF THE RETINA | OREGON STATE UNIVERSITY (OR) | 2024-10-17 | — | — | US | disclosed |
| WO-2023122721-A2 | PEPTIDES FOR CELL-TYPE SPECIFIC TARGETING OF THE RETINA | OREGON STATE UNIVERSITY (US) | 2023-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240343760-A1 | PEPTIDES FOR CELL-TYPE SPECIFIC TARGETING OF THE RETINA | ARGLU1, TPX2, RXFP1 | EPHA2 1164/4885CALCR 706/4885RAMP3 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.